Inocuidad y calidad de los alimentos
|
|
|
Ayuda en línea Terminology
Esta base de datos contiene la información más reciente sobre los niveles máximos de residuos en drogas veterinarias según lo recomendado por JECFA. Todas las monografías publicadas en la FAO sobre Alimentación y Nutrición, Papeles 41, son accesibles en formato electrónico. Estas monografías están sólo disponibles en inglés aunque algunas partes de la base de datos, como la página de preguntas y también una información básica se puede encontrar en árabe, chino, español, francés e inglés.
Medicamento veterinario |
Neomycin |
La clase funcional |
Antimicrobial agent |
Ultima evaluación |
2003 |
Reunión de JECFA |
60 |
IDA |
0-60 µg/kg bw |
Estatus de IDA |
Full |
Monografías de residuos |
|
Definición del residuo |
Parent drug |
Límites máximos para residuos (LMR) recomendados |
Cattle | Fat | 500 µg/kg | F | Cattle | Kidney | 10000 µg/kg | F | Cattle | Liver | 500 µg/kg | F | Cattle | Milk | 1500 µg/kg | F | Cattle | Muscle | 500 µg/kg | F | Chicken | Eggs | 500 µg/kg | F | Chicken | Fat | 500 µg/kg | F | Chicken | Kidney | 10000 µg/kg | F | Chicken | Liver | 500 µg/kg | F | Chicken | Muscle | 500 µg/kg | F | Duck | Fat | 500 µg/kg | F | Duck | Kidney | 10000 µg/kg | F | Duck | Liver | 500 µg/kg | F | Duck | Muscle | 500 µg/kg | F | Goat | Fat | 500 µg/kg | F | Goat | Kidney | 10000 µg/kg | F | Goat | Liver | 500 µg/kg | F | Goat | Muscle | 500 µg/kg | F | Pig | Fat | 500 µg/kg | F | Pig | Kidney | 10000 µg/kg | F | Pig | Liver | 500 µg/kg | F | Pig | Muscle | 500 µg/kg | F | Sheep | Fat | 500 µg/kg | F | Sheep | Kidney | 10000 µg/kg | F | Sheep | Liver | 500 µg/kg | F | Sheep | Muscle | 500 µg/kg | F | Turkey | Fat | 500 µg/kg | F | Turkey | Kidney | 10000 µg/kg | F | Turkey | Liver | 500 µg/kg | F | Turkey | Muscle | 500 µg/kg | F |
|
Otras observaciones |
|
El resumen de la evaluación |
Committee considered the following factors in recommending MRLs: - An ADI of 0 - 60 mg/kg bodyweight based on a toxicological end-point, which results in a maximum daily intake of 3600 mg for a 60 kg person. - Neomycin undergoes negligible metabolism following parenteral administration in animals and the parent drug represents the total of the residues present in the tissues. - Neomycin is the marker residue for tissues, milk and eggs. - A validated HPLC method with a LOQ of 0.1 mg/mL for neomycin in cow's milk is available and is suitable for routine use. - Concentrations of neomycin up to 2 mg/l had no effect on bacterial starter cultures used in the production of fermented milk products. - Data on residues in milk supported an MRL for cow's milk of 1500 mg/kg. - Information on the registered use patterns for injectable formulations of neomycin in food-producing animals was requested from Governments and considered. The information indicated that use of parenteral formulations is not regarded as good practice in the use of veterinary drugs, and few such products were found to be approved. - The MRLs for kidney of 20000 mg/kg and for liver of 15000 mg/kg recommended by the Committee at its 52nd Meeting to accommodate use of parenteral formulations are therefore unnecessary. The Committee, having considered the data submitted since its 43rd meeting, decided to revert to the MRLs for cattle kidney and liver that it had recommended at its 47th meeting. Based on the consumption of 300 g of muscle, 100 g of liver, 50 g of kidney, 50 g of fat, 1.5 kg of milk and 100 g of eggs, the theoretical maximum daily intake of neomycin residues is 3025 mg. This accounts for 84 % of the ADI of 3600 mg for a person of 60 kg bodyweight. FNP 41/15 |
|
|
|